АНТИ-VEGF-АНТИТЕЛО И СОДЕРЖАЩАЯ ЕГО ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ, ДИАГНОСТИКИ ИЛИ ЛЕЧЕНИЯ РАКА ИЛИ СВЯЗАННОГО С АНГИОГЕНЕЗОМ ЗАБОЛЕВАНИЯ
The present invention relates to: a novel anti-vascular endothelial growth factor (VEGF) antibody having a strong binding affinity for VEGF and capable of inhibiting in vivo tumor growth and a composition for the treatment of cancer, containing the same. The antibody of the present invention shows a remarkable binding property to human and mouse VEGF, suppresses the proliferation and permeability of a human umbilical vein endothelial cell (HUVEC) and inhibits tumor growth, and thus can be useful as an antibody for the treatment of cancer.